pallavi's blog

Neuroscience Market: Introduction According to the report, the global neuroscience market was valued at US$ 28.5 Bn in 2020 and is projected to expand at a CAGR of ~4% from 2021 to 2031. Increase in patient population with neurological disorders such as dementia, Alzheimer's disease, and Parkinson's disease and advancements in the field of neuro-technology and neuroscience are anticipated to drive the global neuroscience market from 2021 to 2031. North America is expected to account for a significant share of the global neuroscience market during the forecast period. Growth of the market in the region can be attributed to well-established healthcare infrastructure, early adoption of technologically advanced products, surge in patient population with various neurological disorders, and high per capita healthcare expenditure. The market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2031. Increase in patient awareness about various neurological disorders and rise in healthcare expenditure in countries such as China, Japan, and India are projected to drive the neuroscience market in the region. Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49641 Rise in Burden of Brain-related Disorders to Propel Market Brain-related disorders primarily include Alzheimer’s, dementia, brain cancer, epilepsy, seizures, mental disorders, Parkinson’s, and other movement disorders, stroke, and transient ischemic attack (TIA). Genetic disorders, congenital abnormalities, lifestyle or environmental health problems, including malnutrition, spinal cord injuries, brain injury, and nerve injury are primary causes of neurological problems. According to the World Health Organization, epilepsy is a highly common serious brain disorder across the world, and an estimated two million new cases occur each year globally. Dementia is one of the major causes of disability, and it affects elderly people. Hence, increase in geriatric population leads to rise in the number of patients, which, in turn, drives the market. Nearly 50 million people have dementia and around 10 million new cases are recorded globally every year. Alzheimer's disease is a highly common form of dementia, and accounts for 60% to 70% of cases worldwide. According to the Blue Cross Blue Shield Association, around 90,000 commercially insured adults between the ages of 30 and 64 were diagnosed with Parkinson’s disease in 2017. Request for Analysis of COVID19 Impact on Neuroscience Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49641 Mental illness is common in the U.S. Nearly one in five U.S. adults lives with mental illness. According to the National Institute of Mental Health, an estimated 51.5 million adults aged above 18 suffered from mental illness in the U.S. in 2019, and the prevalence is higher among females. Therefore, rise in prevalence of brain-related disorders is anticipated to propel the global market. Whole Brain Imaging Technology to Dominate Global Market In terms of technology, the global neuroscience market has been classified into whole brain imaging, neuro-microscopy, electrophysiology, neuroproteomic analysis, animal behavior analysis, neuro-functional analysis, and others. The whole brain imaging segment is expected to dominate the global neuroscience market by 2031. The emergence of advanced technologies such as electroencephalography, fMRI, and magnetoencephalogram is likely to fuel the growth of the segment. Buy Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=49641<ype=S Instruments to be Preferred over Other Components Based on component, the global neuroscience market has been categorized into instrument, software, and services. The instrument segment is projected to dominate the global neuroscience market during the forecast period due to establishment of advanced technologies and high cost of neuroscience instruments. Diagnostic Laboratories to be Major End Users In terms of end user, the global neuroscience market has been divided into hospitals, diagnostic laboratories, academic & research institutions, and others. The diagnostic laboratories segment is anticipated to account for a significant share of the global neuroscience market by 2031. Rise in awareness about early diagnosis is expected to augment the segment. Moreover, increase in the number of diagnostic centers with a range of service offerings is likely to boost the segment. Competition Landscape The report provides profiles of leading players operating in the global neuroscience market. These include Doric Lenses, GE Healthcare, Siemens Healthineers, Laserglow Technologies, Mightex Systems, NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Cercare Medical A/S, Plexon, Inc., Noldus Information Technology bv, Femtonics Ltd., and Neuralynx. Browse more Market Reports: Intra-Abdominal Pressure Measurement Devices Market: https://www.transparencymarketresearch.com/intraabdominal-pressure-measurement-devices-ipmd-market.html Cancer Supportive Care Products Market: http://www.transparencymarketresearch.com/cancer-supportive-care-products-market.html Infection Prevention Devices Market: https://www.transparencymarketresearch.com/infection-prevention-devices-market.html About Us: Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial! Contact Us Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/
Respiratory Antiviral Treatment Market: Introduction According to the report, the global respiratory antiviral treatment market was valued at US$ 2.9 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Antiviral drugs are therapeutics that prevent the development and replication of virus without affecting host cells. These drugs do not destroy their target virus, as it is an obligatory intracellular parasite. Instead, these inhibit their propagation by deactivating the viral enzymes. Different types of drugs are used in the treatment of respiratory viral diseases including ribavirin, aciclovir, oseltamivir, zanamivir amantadine, and amantadine. The growth of the global respiratory antiviral treatment market can be ascribed to rise in prevalence of respiratory viral diseases and ongoing clinical trials, and increase in FDA approvals. Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77000 Outbreak of Pandemic Respiratory Viral Diseases, Ongoing Clinical Trials, and Increase in FDA Approvals to Drive Global Market The rise in prevalence and incidence of respiratory viral diseases such as influenza and bronchiolitis across the globe is a key factor driving the global respiratory antiviral treatment market. The WHO estimated that around 3 million to 5 million influenza cases occur globally every year; 250,000 to 500,000 of these result in deaths. Hence, increase in incidence of influenza continues to encourage the use of influenza medication, thereby driving the market. According to the CDC, COVID-19 pandemic resulted in over 814,000 deaths globally, as of August 2020. Ongoing clinical trials for respiratory viral disease treatment, drugs, pipeline products, and safety and efficacy studies have increased over the past few years. Moreover, marketing approvals for antiviral therapies and drugs by the FDA and other authorities in different regions are expected to boost the growth of the global respiratory antiviral treatment market. In October 2019, Genentech, Inc. received the U.S. Food and Drug Administration (FDA) approved for Xofluza (Baloxavir Marboxil) for people at high risk of developing influenza-related complications. Request for Analysis of COVID19 Impact on Respiratory Antiviral Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77000 Neuraminidase Inhibitors to Dominate Respiratory Antiviral Treatment Market In terms of drug class, the global respiratory antiviral treatment market has been divided into nucleoside analogs, neuraminidase inhibitors, ion channel blockers, and fusion protein inhibitors. The neuraminidase inhibitors segment dominated the global respiratory antiviral treatment market in 2019. This trend is likely to continue during the forecast period. Oseltamivir is first-line treatment for several respiratory viral diseases such as influenza. It is available as a prodrug oseltamivir phosphate and is converted by the liver to active metabolite oseltamivir carboxylate. The mechanism of action of oseltamivir carboxylate and other NAIs is to interfere with the release of influenza viral particles from infected host cells by binding to influenza viral neuraminidase, resulting in reduced spread of influenza viruses in the respiratory tract. This factor is projected to drive the segment. Nucleoside analogs was the second largest segment in terms of market share in 2019. The growth of the segment can be attributed to increase in demand for nucleoside analogs, owing to rise in occurrence of seasonal influenza and RSV infection. Buy Respiratory Antiviral Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77000<ype=S Influenza to be Main Disease In terms of disease type, the global respiratory antiviral treatment market has been categorized into influenza, bronchiolitis, pneumonia, upper respiratory tract infections (URTIs), and others (measles, etc.). The influenza segment accounted for prominent share of the global respiratory antiviral treatment market in 2019, owing to rise in number of patients and awareness about the disease. According to the World Health Organization, around 1 billion influenza cases are reported globally each year, and 300,000 to 500,000 deaths occur due to influenza in every year. Hospital Pharmacies to be Major Distribution Channel In terms of distribution channel, the global respiratory antiviral treatment market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment led the global respiratory antiviral treatment market in terms of revenue in 2019. The trend is expected to continue during the forecast period. Rapid increase in the number of hospitals and wide range of services available in multispecialty hospitals are likely to augment the segment during the forecast period. The surge in the number of patients opting for retail pharmacies due to a large number of product brands available at discounted prices at these pharmacies is projected to drive the retail pharmacies segment during the forecast period. North America to Dominate Respiratory Antiviral Treatment Market The global respiratory antiviral treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global respiratory antiviral treatment market in 2019, followed by Europe. North America’s large market share can be ascribed to increase in the number of people with respiratory viral diseases, new product launches, and presence of major players in the region. According to the CDC, around 5.6 million patients are suffering from COVID-19 in the U.S., as of August 2020. The respiratory antiviral treatment market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. This can be ascribed to the presence of developing countries with commercial hubs, expanding business organizations, rise in awareness about respiratory antiviral, improving healthcare infrastructure, and increase in investments by companies in their technical aspects. Competition Landscape of Respiratory Antiviral Treatment Market The global respiratory antiviral treatment market is fragmented in terms of number of players. Key players operating in the global market include F. Hoffmann-La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Mylan, Inc., Merck & Co., Inc., and AstraZeneca plc. Browse more Market Reports: Multiplex Molecular Diagnostics Market: https://www.transparencymarketresearch.com/multiplex-molecular-diagnostics-market.html Substance Use Disorder Treatment Market: https://www.transparencymarketresearch.com/substance-use-disorder-treatment-market.html Dental Veneers Market: https://www.transparencymarketresearch.com/dental-veneers-market.html About Us: Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial! Contact Us Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/

Pharmaceutical Testing and Analytical Services Market: Introduction

According to the report, the global pharmaceutical testing and analytical services market was valued at US$ 3.5 Bn in 2019. It is projected to expand at a CAGR of ~11% from 2020 to 2030. Pharmaceutical testing and quality assurance are important stages in the pharmaceutical industry. Testing and analysis are carried out as people’s lives depend on the quality and quantity measure of a given medicine. Bioanalytical testing, method development & validation, raw material testing, stability testing, and microbial testing are commonly employed tests adopted in pharmaceutical and medical devices industries. The expansion of the global pharmaceutical testing and analytical services market can be ascribed to rise in the number of clinical trials and increase in R&D spending.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55191

 North America dominated the global pharmaceutical testing and analytical services market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players who are focused on design and development of new treatment options for the treatment of major chronic diseases is likely to further drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global pharmaceutical testing and analytical services market. It is projected to expand at a rapid pace during the forecast period.

Request for Analysis of COVID19 Impact on Pharmaceutical Testing and Analytical Services Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55191

Rise in Number of Clinical Trials and Increase in R&D Spending to Drive Global Market

The increase in the number of clinical trials is projected to boost the pharmaceutical testing and analytical services market. Rising prevalence of cancer is a key factor driving the number of clinical trials being conducted. Furthermore, it is estimated that the number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. Increase in R&D spending and focus of biopharmaceutical companies on boosting revenues has propelled the pharmaceutical testing and analytical services market.

Inorganic growth is a key strategy adopted by major players operating in the pharmaceutical testing and analytical services market in order to consolidate their position in the market. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market. These factors are estimated to propel the pharmaceutical testing and analytical services market during the forecast period.

Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=55191&ltype=S

Bioanalytical Testing Segment to Dominate Global Market

Based on service type, the global pharmaceutical testing and analytical services market has been divided into bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further segmented into cell-based assays, virology testing, and others. The method development & validation segment has been sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. The raw material testing segment has been split into heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others. The bioanalytical testing segment dominated the global pharmaceutical testing and analytical services market in 2019. This trend is projected to continue during the forecast period.

 Ask for Discount:

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=55191

Competition Landscape of Pharmaceutical Testing and Analytical Services Market

The global pharmaceutical testing and analytical services market is fragmented in terms of number of players. Key players operating in the global market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc, RD Laboratories, Inc., WuXi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma.

 Browse more Market Reports:

Malaysia Medical Tourism Market         

https://www.transparencymarketresearch.com/malaysia-medical-tourism-market.html

Brain Hemorrhage Treatment Market   

http://www.transparencymarketresearch.com/brain-hemorrhage-treatment-market.html

Circulating Biomarkers Market 

https://www.transparencymarketresearch.com/circulating-biomarkers-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Pelvic Floor Electrical Stimulation Devices Market: Introduction

According to the report, the global pelvic floor electrical stimulation devices market was valued at US$ 300 Mn in 2019 and is projected to expand at a CAGR of 9.5% from 2020 to 2030. The electrical stimulation is a therapeutic treatment for muscle spasms and pain. It prevents atrophy and builds strength in patients with injuries. Electrical muscle stimulation can be used to strengthen weak pelvic floor muscles. Most electrical stimulation devices require insertion of electrical probes into the vaginal opening and rectally in men for pelvic floor muscle strengthening. Mobile pelvic floor electrical stimulation devices are portable, non-implantable, and handheld, and used for electrical stimulation of pelvic floor for the treatment of pelvic floor diseases such as urinary incontinence, fecal incontinence, and sexual dysfunction.

Fixed pelvic floor electrical stimulation devices are non-implantable, stationary, tabletop models of pelvic floor electrical stimulation devices used in the treatment of pelvic floor diseases. These devices consist of the whole system of electrical stimulator, laptops, electrical probes, and printer. North America dominated the global pelvic floor electrical stimulation devices market in terms of revenue in 2019 and the trend is expected to continue during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17438

Rise in Prevalence of Urinary Incontinence and Other Pelvic Floor Disorders to Drive Global Market

The rise in prevalence of urinary incontinence and other pelvic floor disorders, and favorable medical reimbursement policies are the major factors boosting the growth of the global pelvic floor electrical stimulation devices market. According to the International Continence Society, overactive bladder affects around 12% of both men and women, and the incidence increases with age. Electrical stimulation devices for the treatment of stress and urge urinary incontinence are covered as the reasonable and necessary treatment devices by the Centers for Medicare and Medicare Services (CMS) in the U.S. The increase in the geriatric population, which is more prone to pelvic floor disorders, also fuels the growth of the global pelvic floor electrical stimulation devices market

Technologically advanced products with comparatively lower price are driving the global pelvic floor electrical stimulation devices market.

Request for Analysis of COVID-19 Impact on Pelvic Floor Electrical Stimulation Devices Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=17438

Mobiles to Dominate Global Market

In terms of product type, the global pelvic floor electrical stimulation devices market has been bifurcated into mobile and fixed. The mobile segment accounted for a major share of the global market in 2019 due to cheaper pricing compared to implantable devices, rise in regulatory approvals for current products to use as OTC products, and patient convenience to use portable device at home or office.

Urinary Incontinence Treatment to be Promising Application

Based on application, the global pelvic floor electrical stimulation devices market has been classified into urinary incontinence treatment, neurodegenerative diseases, sexual dysfunction, and others. The urinary incontinence treatment segment dominated the global pelvic floor electrical stimulation devices market in 2019 and the trend is expected to continue from 2020 to 2030. The urinary incontinence treatment is also likely to be a highly lucrative segment during the forecast period. The segment is projected to expand at a high CAGR from 2020 to 2030, owing to the increase in incidence and higher prevalence of urinary incontinence, rise in demand for non-invasive electrical stimulation devices, new product launches in the past few years, and increase in geriatric population.

Buy Pelvic Floor Electrical Stimulation Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=17438&ltype=S

Hospitals to be Major End User

In terms of end user, the global pelvic floor electrical stimulation devices market has been divided into hospitals, clinics, home care settings, and others. The hospitals segment accounted for a major share of the market in 2019, due to the increase in the number of hospitals, favorable reimbursement, and early adoption of advanced products at hospitals.

North America to Dominate Global Market

In terms of region, the global pelvic floor electrical stimulation devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global pelvic floor electrical stimulation devices market in 2019, owing to higher patient population of urinary incontinence & other pelvic floor disorders, regulatory approvals for innovative products in the past few years, favorable insurance coverage, and presence of major companies. According to the Global Forum on Incontinence estimates, the prevalence of urinary incontinence in North America is estimated at around 9%, which is around 37 million people in the region.

The market in Asia Pacific is projected to expand at a higher CAGR during the forecast period, owing to increase in geriatric population, which is more prone to urinary incontinence, rise in awareness about electrical stimulation devices, surge in demand for mobile products, increase in distribution tie-ups between major companies, and rise in investments by major companies in the region.

 Top of Form

 Ask for Discount :

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=17438

Competition Landscape

The global pelvic floor electrical stimulation devices market is fragmented in terms of the number of players with the entry of several new players. Key players in the global market include Atlantic Therapeutics, Utah Medical Products, Inc., The Prometheus Group, Shenzhen XFT Medical Limited, KayCo 2 Ltd., Zynex Medical, TensCare Ltd., Laborie, Inc., Verity Medical Ltd., Tic Medizintechnik GmbH, and InControl Medical Limited. Mergers, acquisitions & strategic collaborations, distribution tie-ups, and new product launches with advanced features are the major strategies adopted by leading companies in the global pelvic floor electrical stimulation devices market.

Browse more Market Reports:

Fetal Bovine Serum Market       

https://www.transparencymarketresearch.com/fetal-bovine-serum-market.html

Cystatin C Testing Market           

https://www.transparencymarketresearch.com/cystatin-c-testing-market.html

Hospital Asset Tracking and Inventory Management Systems Market   

https://www.transparencymarketresearch.com/hospital-asset-tracking-and-inventory-management-systems-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Transparency Market Research (TMR) has published a new report titled, ‘Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global cardiac biomarker diagnostic kits market was valued at around US$ 2.2 Bn in 2018 and is projected to grow at a CAGR of 5.2% from 2019 to 2027

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62931

Overview

  • Cardiac biomarkers are also called cardiac markers. In a condition when the heart is damaged or stressed, cardiac biomarkers (endogenous substances including enzymes, hormones, and proteins) are released into the blood.
  • Generally, cardiac markers are used to diagnose heart attack and acute coronary syndrome (ACS) or conditions associated with insufficient blood flow to the heart. These markers are also utilized in the diagnosis and risk stratification of patients with chest pain.
  • Among cardiac biomarker tests, troponin is the biomarker test of choice for detecting heart damage. The test is performed with a blood sample using a needle to draw blood from a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and stays elevated up to two weeks.
  • There are other established biomarkers, such as myoglobin (test used along with troponin for early detection of heart attack) and creatinine kinase isoenzymes (also called cardiac enzyme, which is linked with injury of heart muscle and detection of a second heart attack anticipated shortly after the first)

Request for Analysis of COVID-19 Impact on Cardiac Biomarker Diagnostic Kits Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62931

Rise in prevalence of cardiovascular diseases across the world to Drive Market

  • Growing prevalence of cardiovascular diseases across the world is the major driver for the growth of global cardiac biomarker diagnostic kits market.
  • For instance, the American Heart Association estimated that 121.5 million adults had cardiovascular diseases between 2013 and 2016
  • Advancements in novel technologies and increasing government funding for cardiovascular disease treatment are some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market
  • Moreover, early detection to track the heart condition and integration of cardiology & IT are also some of the major factors fuelling the growth of global cardiac biomarker diagnostic kits market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=62931

Troponin Test Kits Segment to Dominate Market

  • Based on product, the global cardiac biomarker diagnostic kits market has been segmented into troponin test kits, CK-MB test kits, myoglobin test kits, BNP test kits, C-reactive Protein (hsCRP), and other biomarkers
  • Troponin test kits segment is accounted for major market share in global cardiac biomarker diagnostic kits market in 2018
  • Growth of troponin test kits segment can be ascribed to its prodigious specificity and ability to accurately detect the cardiac events of acute coronary syndrome (ACS).

Buy  Cardiac Biomarker Diagnostic Kits Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=62931&ltype=S

North America to Dominate Global Market

  • In terms of region, the global cardiac biomarker diagnostic kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America accounted for major share of the global cardiac biomarker diagnostic kits market in 2018 due to higher cardiovascular disease patient population, significant average selling price of analyzers, rise in demand for technologically advanced diagnostic instruments with enhanced specificity and precision among cardiologist, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region
  • For instance, an article published in the Medscape states that more than 9.8 million people in the U.S. experience symptoms of angina, annually, and more than 500,000 cases are registered every year
  • The cardiac biomarker diagnostic kits market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be ascribed to growing aging population, developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region.

Competitive Landscape

  • The global cardiac biomarker diagnostic kits market is consolidated as few players hold major market share in global market. Key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., among other

Browse More Trending Reports by Transparency Market Research:      

Tranquilizer Drugs Market: https://www.transparencymarketresearch.com/tranquilizer-drugs-market.html

Congenital Adrenal Hyperplasia Market: https://www.transparencymarketresearch.com/congenital-adrenal-hyperplasia-market.html

Dental Infection Treatment Market: https://www.transparencymarketresearch.com/dental-infection-treatment-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Surgical Equipment Market: Introduction

According to the report, the global surgical equipment market was valued at US$ 9.7 Bn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Surgical equipment consists of endo mechanical and electrosurgical devices that are used in minimal invasive surgeries as well as open or invasive surgeries. Most common endomechanical devices are staplers, trocars, ligation kits, and forceps. These devices use mechanical stress or power to perform procedures such as ligation, hemostasis, and access to surgical area. Electrosurgical devices utilize high frequency electrical current to cut, coagulate, and desiccate tissues. Electrical devices comprise generators and accessories or consumables. Based on their mode of action, the accessories can be categorized into monopolar accessories, bipolar accessories, and vessel sealer instruments. North America dominated the global surgical equipment market in 2019. The trend is anticipated to continue during the forecast period. Rise in healthcare spending and rapid adoption of advanced surgical equipment are expected to drive the market in the region.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=183

Surge in Demand for Minimally Invasive Procedures to Drive Global Surgical Equipment Market

Minimally invasive procedures are witnessing increased demand across all medical specialties due to advantages associated with these surgeries. The advantages include precise incision, minimal blood loss, reduced post-surgery complications & side effects, faster recovery span, and shorter duration of hospital stay. Electrosurgical devices play a key role during minimally invasive procedures. Rise in demand for these procedures is expected to drive the market, especially the electrosurgical devices segment

Surgical Sutures and Staples to Dominate Global Market

In terms of product, the global surgical equipment market has been classified into surgical sutures & staples, handheld instruments, and electrosurgical devices. Surgical sutures & staples are widely utilized surgical equipment. Ethicon, Inc., B. Braun Melsungen AG, and Covidien plc are major manufacturers of surgical sutures and staples, and actively promote their brands through various marketing strategies such as launches of advanced cutting staplers, and price discount in the market. This drives the demand for the product.

Request for Analysis of COVID19 Impact on Surgical Equipment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=183

Surgical Equipment to be Majorly Used in General Surgeries

Based on application, the global surgical equipment market has been categorized into ophthalmology, gynecology, general surgery, bariatric surgery, and plastic surgery. The general surgery segment held a major share of the global market in 2019, as abdominal surgeries including esophagus, stomach, small intestine, large intestine, liver, pancreas, gallbladder, appendix and bile ducts, and often the thyroid gland are rising across the globe.

Hospitals to be Highly Lucrative End User

In terms of end user, the global surgical equipment market has been divided into hospitals, ambulatory surgical centers, and clinics. Higher number of operation theaters in hospitals is fueling the demand for surgical instruments. Moreover, the number of hospitals is increasing the regions, such as Asia Pacific and the Middle East, which is boosting the demand for new shipment of surgical equipment.

Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=183&ltype=S

North America to Dominate Global Surgical Equipment Market

In terms of region, the global surgical equipment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global surgical equipment market in 2019, followed by Europe. North America accounted for a major share of the global surgical equipment market in 2019, primarily due to significant favorable reimbursement for surgeries, which drives preference among patients to undergo surgery and adoption of advanced surgical equipment in healthcare institutes.

Competition Landscape of Surgical Equipment Market

The global surgical equipment market is fragmented in terms of number of players. Key players in the global surgical equipment market include Medtronic plc, CONMED Corporation, Olympus Corporation, BD, Stryker, Meril Life Science Pvt. Ltd., Integra Lifescience Corporation, Ethicon, Inc., and Healthium Ltd.

 Top of Form

 Browse more Market Reports:

Mobile Hospitals Market            

http://www.transparencymarketresearch.com/mobile-hospitals-market.html

Saliva Collection Devices Market            

https://www.transparencymarketresearch.com/saliva-collection-devices-market.html

Medication Dispenser Market  

http://www.transparencymarketresearch.com/medication-dispenser-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market: Introduction

According to the report, the global ornithine transcarbamylase (OTC) deficiency treatment market was valued at ~US$ 600 Mn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Ornithine transcarbamylase (OTC) deficiency is a rare X-linked genetic disorder characterized by partial or complete lack of the enzyme ornithine transcarbamylase (OTC). OTC is one of six enzymes that play a role in the breakdown and removal of nitrogen in the body, a process known as urea cycle. Ammonia-scavenging drugs have been utilized in the treatment of urea cycle disorders. Benzoate and Glycerol/Sodium Phenyl Butyrate (NaPB) target liver-nitrogen metabolism by offering an alternative pathway for nitrogen disposal through the urinary excretion of hippurate and phenylacetylglutamine. A combination of a high biological value natural protein, an essential amino acid formula and a calorie supplement without protein and essential amino acids supplements may also be employed for the treatment of ornithine transcarbamylase deficiency. 

North America dominated the global ornithine transcarbamylase (OTC) deficiency treatment market in 2019. It is expected to dominate the global market, in terms of revenue, during the forecast period.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78569

Rise in Prevalence of Ornithine Transcarbamylase (OTC) Deficiency and Development of New Therapies to Drive Global Market

The surge in the number of patients with ornithine transcarbamylase (OTC) deficiency is likely fuel the global ornithine transcarbamylase (OTC) deficiency treatment market. The development of new therapies for ornithine transcarbamylase (OTC) deficiency treatment in the near future and favorable reimbursement policies for OTC deficiency treatment coupled with various patient assistance programs provided by several international and regional organizations are major factors driving the global ornithine transcarbamylase (OTC) deficiency treatment market.

For instance, in January 2020, The Assistance Fund (TAF), an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, announced the launch of a new financial assistance program for people living with urea cycle disorders. Formulation modification for better patient compliance is also a key factor driving the global ornithine transcarbamylase (OTC) deficiency treatment market.

 Request for Analysis of COVID19 Impact on Ornithine Transcarbamylase (OTC) Deficiency Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78569

Ravicti to Dominate Global Market

Based on product, the global ornithine transcarbamylase (OTC) deficiency treatment market has been segmented into Buphenyl, Ravicti, Ammonul, dietary supplements, and others. The Ravicti segment accounted for a major share of the global market in 2019 due to higher efficacy and cost of drug, and better patient compliance, which contributes toward higher revenues. The Buphenyl segment followed the Raviciti segment, in terms of share of the global market, in 2019, owing to pipeline products with improved patient compliance and lesser cost to patients.

Oral a Preferred Route of Administration

In terms of route of administration, the global ornithine transcarbamylase (OTC) deficiency treatment market has been bifurcated into oral and intravenous. The oral segment dominated the global ornithine transcarbamylase (OTC) deficiency treatment market in 2019. It is expected to maintain its dominant share by 2030. Oral is also a highly lucrative segment. It is projected to expand at a notable CAGR during the forecast period, owing to patient preference for oral route and convenience offered by the oral route, approval & launch of oral medication, availability of a large number of products that can be administered through oral route, and new products with improvement in formulation modification for taste masking.

 Buy Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=78569&ltype=S

North America to Dominate Global Market

In terms of region, the global ornithine transcarbamylase (OTC) deficiency treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global ornithine transcarbamylase (OTC) deficiency treatment market in 2019, owing to a rise in the total number of reported cases of ornithine transcarbamylase (OTC) deficiency, favorable reimbursement policies, presence of major companies, various clinical studies in the region for urea cycle disorder, and better screening approaches for rare diseases. For instance, according to the U.S. National Library of Medicine, prevalence of ornithine transcarbamylase deficiency have ranged from 1 in 14,000 to 1 in 77,000 people in the U.S. The market in Asia Pacific is projected to expand at a higher CAGR during the forecast period, owing to increase in awareness about ornithine transcarbamylase (OTC) deficiency and other urea cycle disorders, surge in screening of patients for the diagnosis of ornithine transcarbamylase (OTC) deficiency, increase in distribution tie-ups between major companies, and rise in investments by major companies in the region.

Competition Landscape

The global ornithine transcarbamylase (OTC) deficiency treatment market is fragmented in terms of the number of players, with entry of several new players. Key players in the global market include Abbott, Nutricia (Danone Group), Mead Johnson (Reckitt Benckiser), Horizon Therapeutics plc, Nestlé, Bausch Health Companies, Inc., Ultragenyx Pharmaceutical Inc., Arcturus Therapeutics, Inc., and Acer Therapeutics. Mergers, acquisitions & strategic collaborations, distribution tie-ups, increased research & development expenditure, and new product launches are major strategies adopted by companies in the global ornithine transcarbamylase (OTC) deficiency treatment market.

Browse more Market Reports:

Assistive Listening Devices Market:

https://www.transparencymarketresearch.com/assistive-listening-devices-market.html

Portable Oxygen Concentrators Market:

https://www.transparencymarketresearch.com/portable-oxygen-concentrators.html

Aromatherapy Market:

https://www.transparencymarketresearch.com/aromatherapy-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Global Calcitriol Market: Overview

Globally, the demand for calcitriol has grown considerably due to high number of bone-related disorders rising across the globe. Moreover, increasing investments in research and development of novel drugs and patent expiration of branded drugs has created new growth opportunities for the global calcitriol market.

The global calcitriol market is likely to be classified on the basis of distribution channel, product, and application. In terms of application, the market is segmented into renal osteodystrophy, osteoporosis, and others. On the basis of product type, the market is categorized into calcitriol solution, calcitriol capsule, and others.

The report discusses about the various growth factors driving the global calcitriol market. It also presents a comprehensive overview combining both the drivers and restrains that may occur in the coming years. Apart from in-depth analysis, statistics and facts are also given in the report. Economic trends and regulatory policies are also presented in the report to give a complete picture of the global calcitriol market. To have a better understanding about the regional growth and existing market competition that has also been illustrated in the report.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55695

Global Calcitriol Market: Trends and Opportunities

According to the data provided by the International Osteoporosis Foundation, there are more than 8.9 million fractures reported per year due to osteoporosis across the globe. Therefore, the rapid growth in the osteoporosis has significantly boosted the demand for calcitriol. Growing prevalence of hypoparathyroidism is also considered as a major factor fueling the calcitriol market. Moreover, rising technological advancements and growing investment in healthcare may also expand the calcitriol market. These factors are expected to drive demand in the global calcitriol market in the coming years.

On the other hand, intellectual property rights and strict regulatory policies might hamper the growth in this market.

 Request for Analysis of COVID19 Impact on Calcitriol Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55695

Global Calcitriol Market: Geographic Analysis

From regional point of view, the global calcitriol market covers North America, the Middle East and Africa, Latin America, Asia Pacific, and Europe. Among these regions, North America is projected to lead the market, as the prevalence of osteoporosis and other bone-related disorders is high in the region. Europe is also expected to grow at a significant rate in the coming years. Technological advanced healthcare infrastructure is the key reason behind this growth.

Asia Pacific is expected to rise at a significant rate and contribute largely in the global calcitriol market. Rising investment in the healthcare sector mainly in countries like China and India is expected to drive demand in this market. In addition, rising number of bone-related disorders stoke up the demand for calcitriol in the region.

 Pre Book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=55695&ltype=S

Global Calcitriol Market: Competitive Landscape

In order to understand prevailing competition in the market, the report also gives information on some of the leading players operating in the global calcitriol market. The report presents strengthen and weaknesses of these companies and provides information about various strategies used by these players. Developing new products, innovation, expanding business through mergers, acquisitions, and partnership are some of the key strategies used by the leading players. Moreover, information provided in this section helps in gaining competitive edge and expanding their customer base. Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals, Hikma Pharmaceuticals PLC, and Akorn, Incorporated, are some the leading players functioning in the global calcitriol market.

Read More Information:

https://www.transparencymarketresearch.com/calcitriol-market.html

Browse more Market Reports:

Electronic Stethoscope Market:

https://www.transparencymarketresearch.com/electronic-stethoscopes-market.html

Wearable Injectors Market:

https://www.transparencymarketresearch.com/wearable-injectors-market.html

Veterinary Biologics Market:

https://www.transparencymarketresearch.com/veterinary-biologics-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Global Antiulcerant Drugs Market: Overview

Antiulcerant drugs are a wide class of drugs used in treating ulcers of the stomach and intestine. Some of the popular antiulcerant drugs used currently are H2 receptor antagonists, gastric mucosal protective drugs, antacids, and antibiotics. They are also used as proton pump inhibitors as co-treatment in patients with the risk of gastrointestinal bleeding events such as those taking aspirin. Their use prevents the production of gastric acid by stomach and lower part of abdomen. The rising instance of heartburn and indigestion caused by the production of excess stomach acid has helped antiulcerant drugs occupy significant role in the treatment of stomach ulcers. Some antiulcerant drugs are also gaining popularity in the treatment of diarrhea or address an irritable gastrointestinal tract in patients.

The various evaluations of the growth dynamics of the global antiulcerant drugs market will offer insights and projections for emerging as well as new entrants to help them tap into lucrative avenues. The assessments can guide interested participants to know recent investment of prominent players on research and development of new drugs.

 Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56031

Global Antiulcerant Drugs Market: Trends and Opportunities

There has been rising awareness about ulcer diseases, which has been imparting an increasing momentum to the evolution of the antiulcerant drugs market. The pipeline of promising antiulcerant drugs has been rising over the past few years in various parts of the world. In recent years, the pharmacology of antiulcerant drugs has received considerable attention by pharmaceutical companies, which has helped them develop drugs with better clinical results. The rising incidence of peptide ulcers, especially in people with sedentary lifestyle, is also catalyzing the growth of the global antiulcerant drugs market. The rising acceptance of antacids in anti-ulcer agents among the patient population for symptomatic relief is also a significant boosting the market.

There is prevalence of infection with H. pylori in communities with the lack of access to clean water and proper sewage systems. This if untreated may lead to peptic ulcer disease, and antiulcerant drugs play crucial role in the treatment. The growing mortality of thrombotic events, especially in tuberculosis patients, is also likely to accentuate prospects of the antiulcerant drugs market in the coming few years. The rising risk of adverse cardiovascular events related to patients treated with aspirin has fueled the uptake of antiulcerant drugs. In recent years, several pharmaceuticals have been actively working to adopt advanced technologies for manufacturing anatacids. Moreover, they are spending sizeable sums on accelerating their drug pipelines. This will open new, exciting avenues in the global market.

 Request for Analysis of COVID19 Impact on Antiulcerant Drugs Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56031

Global Antiulcerant Drugs Market: Regional Outlook

The report on the global antiulcerant drugs market offers a critical assessment of key regional growth dynamics and lucrative avenues in emerging markets. The study also assesses the growth potential of these regions and the trends that will fuel their expansion over the next few years. Regionally, developed regions, notably North America, might generate copious amounts of revenue to the global antiulcerant drugs market. The trend will be supported by the substantial uptake of advanced drug manufacturing technologies in the regions. On the other hand, Asia Pacific is one of the regions that show great potential in the near future. One of the several factors that may contribute to the rising demand for antiulcerant drugs in the region is the growing prevalence of diabetes.

 Pre book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=56031&ltype=S

Global Antiulcerant Drugs Market: Competitive Landscape

The study takes a closer look at recent strategies and drug development initiatives made by various players in the global antiulcerant drugs market. It also highlights major investment measures taken by established players. Some of the prominent companies in the antiulcerant drugs market are Takeda Pharmaceutical, Eisai, Daewoong Pharmaceutical, Allergan, and AstraZeneca plc.

 Read More Information:

https://www.transparencymarketresearch.com/antiulcerant-drugs-market.html

Browse more Market Reports:

Cardiac Biomarker Diagnostic Kits Market:

https://www.transparencymarketresearch.com/cardiac-biomarker-diagnostic-kits-market.html

Urodynamics Equipment and Disposables Market:

https://www.transparencymarketresearch.com/urodynamics-equipment-disposables-market.html

Hematocrit Test Devices Market:

https://www.transparencymarketresearch.com/hematocrit-test-market.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Balantidiasis Treatment Market: Introduction

  • Balantidiasis, also known as Balantidium coli infection, is a disorder caused by Balantidium coli, an intestinal protozoan parasite. The parasite is transmitted through the fecal-oral route. Humans can be infected by the parasite by ingesting infective cysts from food and water contaminated with defecation. This infection predominantly affects the large intestine. Diarrhea, weight loss, dysentery, stomach pain, and vomiting are common side-effects of balantidiasis. The infection is observed to be prevalent in rural areas in industrially advanced and developing regions due to water pollution caused by fecal matter of humans and/or pigs. Provision of safe and clean drinking water can prevent the infection from spreading from one person to the other. Anti-infective agents are utilized to treat balantidiasis.  
  • Most of the people suffering from Balantidiasis are asymptomatic. Some people may become acutely ill with abnormally high temperatures, vomiting, nausea, abdominal pain, and bloody diarrhea. Such conditions could result in excessive loss of water from the body and extreme exhaustion, especially if B. coli attacks the intestinal lining causing inflammation and possibly ‘crater-like’ areas of damage. In serious cases, the ulcers could be deep enough to puncture the intestinal wall, resulting into the acute inflammation of the peritoneum?the membrane that lines the abdomen (peritonitis). Occasionally, the ulcer may diminish lung function.
  • Tetracycline, a common antibiotic drug, is commonly prescribed in the treatment of Balantidiasis. When tetracycline cannot be administered, replacement drug therapy may include iodoquinol or metronidazole. It is not necessary to isolate the person suffering from Balantidiasis. However, the feces of infected individuals must be disposed of so that they don’t came into contact with drinking water or with food supplies.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56175

Key Drivers, Restraints, and Opportunities of Global Balantidiasis Treatment Market

  • Rise in prevalence of balantidiasis infection, surge in the trend of swine farming, increase in research & development activities for the diagnosis of the disease, and surge in awareness about the treatment options are major factors that are projected to propel the balantidiasis diagnosis and treatment market during the forecast period. A study conducted by the Stanford University revealed that incidence of the infection has been reported in Bolivia, Papua New Guinea, and the Philippines. The prevalence rate of balantidiasis infection is lower than 1%. Lower incidence rate in major pharmaceutical markets such as North America and Europe and competition between already established players are likely to restrain the global balantidiasis diagnosis and treatment market, in terms of revenue, during the forecast period.  
  • Additionally, a lack of hygiene and sanitation in rural areas of developing countries is a significant factor that affects the spread of this disease. Furthermore, increasing awareness regarding the diseases transmitted via faecal-oral route further boosts the market. However, competition among existing market players hampers the entry of new players.

 Request for Analysis of COVID19 Impact on Balantidiasis Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56175

Asia Pacific to Capture Major Share of Global Balantidiasis Treatment Market

Based on region, the global balantidiasis treatment market can be classified into North America (the U.S. and Canada), Europe (including Germany, France, and the U.K.), Asia Pacific (including Australia, China, Japan, and India), Latin America (including Brazil and Mexico), and Middle East & Africa (including GCC countries and South Africa).  The disease is less prevalent in North America due to high sanitation standards and quality of living and hygienic environment. However, the disease is more prevalent in Latin America. Additionally, prevalence of the disease is low in Europe due to high hygiene standards, stringent quality control guidelines, hygienic food and water standards, and government support to maintain good hygiene. Asia Pacific and Latin America are emerging regions for the market; therefore, the market in these regions is projected to expand at a significant pace during the forecast period.

 Pre Book Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=56175&ltype=S

Rapid expansion of the balantidiasis treatment market in these regions can be attributed to the increase in incidence of this infection, poor hygiene conditions, expansion of the healthcare industry, and rise in government investment to develop healthcare infrastructure in these regions. The balantidiasis treatment market in countries such as China, India, and Brazil is projected to expand at a high growth rate during the forecast period due to an increase in awareness among the population about protozoal infections and their treatments. Furthermore, the burden of gastrointestinal diseases is rising due to the increase in the number of pylori infection cases and changes in lifestyle such as consumption of alcohol, smoking, and sedentary work profile.

Read More Information:

https://www.transparencymarketresearch.com/balantidiasis-treatment-market.html

Key Players Operating in Global Balantidiasis Treatment Market

The global balantidiasis treatment market is highly fragmented, with the presence of various key players.  A large number of manufacturers hold a major share in their respective regions. Major players operating in the global balantidiasis treatment market are:

  • Sandoz AG
  • 3M
  • Johnson & Johnson Services, Inc.
  • Abbott
  • Koninklijke Philips N.V.
  • Siemens Healthcare Private Limited
  • GENERAL ELECTRIC COMPANY
  • Medtronic, Pfizer Inc.
  • Nurotron Biotechnology Co. Ltd.
  • Sonova
  • BD
  • MicroPort Scientific Corporation.
  • Akorn
  • NuVasive, Inc.
  • Globus Medical
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Novopharm Limited
  • Physicians Total Care, Inc.
  • Amneal Pharmaceuticals LLC.
  • Sanofi
  • Allergan
  • Apotex, Inc.

Browse more Market Reports:

Medical Foods Market:

https://www.transparencymarketresearch.com/medical-foods-market.html

Assistive Technologies Demand for Visually Impaired Market:

https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html

Veterinary Ventilators Market:

https://www.transparencymarketresearch.com/veterinary-ventilators-market.html

 

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: 
https://www.transparencymarketresearch.com/

 

 

Pages: 1 2 3 4 5 ... » »»